How Do You Balance Internal Validity and Real-World Relevance in an RCT?

How Much Experimental Control Is Too Much?

You are designing a randomized controlled trial and want to minimize alternative explanations for the treatment effect. You select participants who are likely to follow instructions, standardize intervention delivery, closely supervise implementation, and schedule assessments under controlled conditions.

These decisions may strengthen certain aspects of the experiment. Yet they may also create conditions that differ from how the intervention would ordinarily be used.

Suppose an AI-assisted learning system improves student achievement when delivered by specially trained instructors to highly motivated students under intensive supervision. Would the same improvement occur when ordinary instructors use the system across a university with varying student needs and limited technical support?

The methodological challenge is to protect the credibility of the causal comparison without making the study unnecessarily distant from the circumstances in which its findings will be applied.

Protect Causal Validity While Matching the Trial to Its Intended Use

Understanding the Relationship Between Causal Credibility and Applicability

What Is Internal Validity in a Randomized Controlled Trial?

Internal validity concerns whether the study supports a credible causal interpretation of the estimated treatment effect for the participants and conditions actually studied.

In an RCT, random assignment helps reduce systematic baseline differences between treatment groups in expectation. When properly implemented, randomization supports comparisons that are less vulnerable to baseline confounding than many nonrandomized comparisons.

However, randomization alone does not guarantee internal validity.

Researchers must also consider allocation concealment, departures from assigned interventions, missing outcome data, outcome measurement, and selective reporting.

For example, a properly randomized trial may still produce a biased estimate if outcome assessors systematically evaluate one treatment group more favorably or if missing outcomes depend on unobserved participant responses.

Internal validity therefore depends on the complete design and conduct of the trial, not merely on the presence of random allocation.

What Is External Validity, and How Is It Different From Generalizability?

External validity concerns whether a causal finding applies beyond the specific participants, settings, treatments, and circumstances studied.

Generalizability commonly refers to applying findings to a broader target population of which the study participants are considered representative or relevant members.

Transportability often refers to applying causal findings to a different target population or setting, potentially using additional assumptions and information about differences between populations.

Terminology varies across methodological traditions, but the underlying question is consistent: under what conditions should the estimated treatment effect be expected to apply elsewhere?

These concepts should not be treated as a simple hierarchy. A study may have strong internal validity but limited applicability, while a broadly representative study may still suffer from serious bias in its causal comparison.

Is There Always a Trade-Off Between Internal and External Validity?

No. The idea that increasing internal validity necessarily reduces external validity is an oversimplification.

Some methodological safeguards can improve causal credibility without making the intervention less realistic. For example, using a concealed randomization sequence, prespecifying outcomes, or employing blinded outcome assessment may strengthen the trial without changing how participants ordinarily receive the intervention.

Other choices involve genuine trade-offs. Restricting eligibility to participants who are highly likely to adhere may reduce certain implementation difficulties but limit applicability to less adherent populations.

Similarly, intensive research-specific support may improve intervention fidelity while producing treatment conditions that would be difficult to reproduce at scale.

The relevant distinction is between controls necessary to protect the causal comparison and controls introduced primarily to create idealized implementation conditions.

Researchers should not relax essential bias protections in the name of realism. Instead, they should identify which aspects of the trial can reflect routine practice without compromising the intended causal inference.

How Do Eligibility Criteria Affect the Balance?

Eligibility criteria determine who can participate and therefore influence the population to which the findings may apply.

Narrow criteria can be justified when participant safety, intervention mechanisms, or the research question require them.

However, unnecessary exclusions may produce a study population that differs substantially from intended users.

For example, an educational technology trial might exclude students with limited digital literacy, inconsistent internet access, or lower prior achievement because these characteristics could complicate implementation.

Such exclusions may simplify delivery, but they also remove students for whom implementation challenges may be especially consequential.

If the intended decision concerns institution-wide adoption, a trial restricted to highly proficient technology users may provide an incomplete estimate of expected effectiveness.

Researchers should distinguish exclusions necessary for ethical or scientific reasons from exclusions adopted primarily for convenience.

Why Does the Study Setting Matter?

Treatment effects may differ across settings because of infrastructure, professional expertise, organizational culture, resources, or participant characteristics.

A trial conducted in a well-resourced teaching hospital may not reproduce the same results in a smaller community facility. Similarly, a digital learning intervention tested in a university with extensive technical support may operate differently in institutions with limited connectivity.

Including multiple settings can improve the evidence available for assessing applicability, particularly when those settings represent meaningful variation in intended implementation environments.

However, recruiting several institutions does not automatically guarantee generalizability. Participating sites may still be unusually motivated or better resourced than nonparticipating institutions.

Researchers should document important contextual characteristics and consider whether those characteristics may modify the treatment effect.

How Much Intervention Standardization Is Necessary?

Standardization can protect the interpretability of a trial by ensuring that participants assigned to an intervention receive a sufficiently defined treatment strategy.

Yet excessive standardization may remove flexibility that is essential to routine practice.

Consider an AI-assisted teaching system. Researchers might require all instructors to use the same software and provide feedback according to common minimum procedures. These requirements help define the intervention.

However, requiring every instructor to deliver identical explanations, use the system for precisely the same number of minutes, and follow an unusually intensive supervision schedule may produce an implementation environment that would not exist after institutional adoption.

A useful approach is to distinguish essential intervention components from adaptable delivery features.

Essential components should be sufficiently specified to preserve the treatment's identity. Adaptable features may vary within documented boundaries when that flexibility is part of the intended implementation strategy.

This distinction supports both reproducibility and real-world relevance without assuming that every instance of implementation must be identical.

What Is the Difference Between Intervention Fidelity and Adherence?

Intervention fidelity generally concerns whether an intervention is delivered as intended. Adherence concerns whether participants follow the assigned treatment or intervention regimen.

The concepts are related but distinct.

An instructor may deliver an AI-supported learning activity exactly as specified, while some students choose not to engage with it. Conversely, students may participate consistently in an intervention that instructors deliver differently from the intended protocol.

Both circumstances can affect the observed treatment contrast.

In explanatory trials, researchers may invest considerable resources in maximizing adherence and fidelity. In pragmatic trials, ordinary variation may be part of the effectiveness question.

However, realistic variation should not be confused with undocumented implementation failure. Researchers still need sufficient information to explain what was delivered and how participants responded.

How Does the Comparator Affect Real-World Relevance?

A trial's estimated treatment effect depends on the alternative against which the intervention is compared.

For example, an AI tutoring system might produce a substantial improvement relative to no additional tutoring but little incremental benefit compared with an established human tutoring service.

Both findings could be scientifically valid. They address different decisions.

If an institution is deciding whether to replace existing tutoring, the active comparator may be more relevant. If the institution currently offers no additional tutoring, comparison with existing practice may be more appropriate.

The choice of control condition should therefore reflect the policy or practice alternative that decision-makers actually face.

A comparator selected merely because it is expected to produce a larger treatment difference may yield findings with limited practical usefulness.

How Should Outcome Measures Balance Precision and Practical Importance?

Outcomes should be sufficiently valid and reliable to support the intended comparison while remaining relevant to the people and institutions affected by the intervention.

Highly standardized laboratory or researcher-developed measures may offer certain measurement advantages, but they do not necessarily capture the outcomes that matter most in practice.

For example, an educational technology intervention might improve performance on a narrow task designed specifically around the software's features. That result does not automatically establish improvement in broader academic competence.

Conversely, routine course grades may be highly relevant to institutional decisions but may vary across instructors, assessments, and grading practices.

The solution is not automatically to prefer standardized or routine outcomes. Researchers should evaluate construct validity, measurement consistency, sensitivity to meaningful change, and decision relevance.

Where appropriate, a trial may include a well-defined primary outcome supported by additional measures that clarify implementation or broader consequences.

Can Blinding Be Preserved in Real-World Trials?

Blinding may reduce bias when participants, intervention providers, or outcome assessors could be influenced by knowledge of treatment allocation.

Some interventions cannot realistically be concealed from participants or providers. Students generally know whether they are using an AI learning system, and instructors know which teaching method they are delivering.

Nevertheless, the inability to blind one group does not mean that all safeguards are unavailable.

Researchers may use blinded outcome assessors, standardized scoring rubrics, objective measurements where suitable, and procedures that limit differential outcome collection.

For example, anonymized student writing samples could be evaluated by assessors unaware of the assigned instructional condition.

Such procedures may strengthen internal validity without substantially altering routine intervention delivery.

How Do Nonadherence and Contamination Affect Interpretation?

Nonadherence occurs when participants do not follow their assigned intervention strategy. Contamination occurs when participants or groups receive components of an intervention assigned to another condition.

Both may reduce the contrast between randomized groups, although their effects on estimated treatment differences are not universally in one direction.

In pragmatic trials, some nonadherence may reflect how the intervention would be used outside research. That variation may be relevant to the effect of offering the intervention.

However, substantial contamination can undermine the distinction between the intended treatment strategies and make the comparison difficult to interpret.

Researchers should anticipate these possibilities when deciding whether to randomize individuals, groups, or sites.

They should also distinguish between estimating the effect of assignment to an intervention and estimating effects under specified adherence conditions.

Why Does the Estimand Matter?

An estimand specifies the treatment effect that the trial seeks to estimate.

The ICH E9(R1) framework describes an estimand through attributes including the treatment conditions, target population, outcome variable, population-level summary measure, and strategy for handling intercurrent events.

Intercurrent events are events occurring after treatment initiation that affect either the interpretation or existence of measurements associated with the research question. Examples may include treatment discontinuation, rescue medication, or switching to another intervention.

For a university evaluating an AI tutoring system, one question might concern the effect of offering the system to all eligible students, regardless of whether they use it consistently.

Another question might concern the effect under a hypothetical condition in which students engage with the system according to a specified regimen.

These questions may require different estimands and analytical assumptions.

The balance between internal validity and real-world relevance becomes clearer when researchers explicitly state which effect is relevant to the intended decision.

Does Intention-to-Treat Analysis Automatically Make a Trial Pragmatic?

No. Intention-to-treat analysis generally compares participants according to their randomized assignment, regardless of subsequent adherence or treatment changes.

This approach often aligns with questions about the effect of offering or assigning an intervention under ordinary conditions.

However, intention-to-treat analysis can also be used in explanatory trials. It is not sufficient to establish that the trial as a whole is pragmatic.

Moreover, simply labeling an analysis intention-to-treat does not resolve missing outcome data or every consequence of treatment switching.

The analysis should correspond to the prespecified estimand and include appropriate methods for missing data and sensitivity analyses.

How Can PRECIS-2 Help Balance Validity and Relevance?

PRECIS-2 provides a structured way to assess whether trial design choices are aligned with an explanatory or pragmatic purpose.

Its nine domains address eligibility, recruitment, setting, organization, flexibility of intervention delivery, flexibility of adherence, follow-up, primary outcome, and primary analysis.

Researchers can examine these domains to identify where a trial departs from routine practice and whether those departures are necessary.

For example, a trial may recruit broadly from ordinary university courses while requiring specialized research staff to deliver the intervention. PRECIS-2 can make this inconsistency visible.

However, PRECIS-2 is not a risk-of-bias assessment and should not be interpreted as a measure of overall trial quality.

Researchers designing pragmatic randomized trials can use the framework to clarify how the intended practice setting should influence each design decision.

How Can Researchers Evaluate Whether Results Apply Elsewhere?

Applicability requires more than reporting that a trial was conducted under realistic conditions.

Researchers should describe participant characteristics, recruitment pathways, intervention resources, provider expertise, institutional context, and important differences between the trial and intended implementation settings.

Where plausible effect modifiers are identified, subgroup or interaction analyses may help investigate treatment-effect heterogeneity. Such analyses should be prespecified where possible and interpreted cautiously, particularly when statistical power is limited.

Methods for generalizing or transporting trial results may also use information about the target population to adjust for differences between trial participants and intended recipients.

These methods require assumptions, including adequate measurement of relevant effect modifiers and sufficient overlap between the trial and target populations.

Statistical adjustment cannot guarantee applicability when important contextual differences remain unmeasured or when the intervention cannot be implemented similarly in the target setting.

Can a Trial Be Internally Valid but Practically Uninformative?

Yes. A trial may estimate a treatment effect credibly under its specified conditions while addressing a comparison that decision-makers rarely encounter.

For example, a carefully controlled study may demonstrate that an AI learning application improves performance relative to receiving no feedback. Yet an institution deciding between AI feedback and its established instructor-feedback system may need a different comparison.

Similarly, a treatment delivered through unusually intensive supervision may produce an effect that cannot be reproduced with ordinary resources.

These are not necessarily failures of internal validity. They are limitations in the relationship between the estimated effect and the intended decision.

Researchers should therefore evaluate causal credibility and practical relevance separately rather than assuming that success in one dimension guarantees success in the other.

Designing an AI-Assisted Learning Trial That Is Both Credible and Applicable

The revised design retains important protections for internal validity, including random allocation, appropriate cluster-adjusted analysis, and safeguards against differential outcome assessment.

At the same time, it allows intervention delivery and student participation to resemble the conditions of intended institutional adoption.

Suppose the intervention produces a modest average improvement, with substantial variation in engagement across course sections. The trial may still provide useful evidence about expected implementation outcomes, even if the estimated effect is smaller than what might be achieved under intensive supervision.

The research team should not interpret that variation automatically as methodological failure. Instead, it should determine whether the variation reflects intended flexibility, implementation difficulties, or factors that meaningfully influence the treatment effect.

With only 24 randomized sections, statistical precision and the reliability of subgroup comparisons would require particular attention. The design's real-world relevance does not eliminate those constraints.

Common Misconceptions About Validity and Real-World Relevance

How to Design an RCT That Supports Both Causal Inference and Practical Decisions

Begin by specifying the population, intervention strategy, comparator, outcome, and decision context. Determine whether the study is intended primarily to establish efficacy under defined conditions or effectiveness in routine practice.

Then distinguish methodological safeguards from implementation restrictions. Preserve procedures that protect the causal comparison, while critically examining restrictions that may make the trial less representative of intended use.

Before finalizing the protocol, examine how the trial's participants and settings compare with the target population. Identify plausible effect modifiers and decide which contextual characteristics must be documented.

Use a risk-of-bias framework to evaluate internal validity and a separate applicability assessment to consider external validity. Neither evaluation should substitute for the other.

The objective is not to maximize realism at the expense of causal inference or maximize control at the expense of usefulness. It is to design a trial whose causal estimate is credible for a question that matters.

Before Finalizing the Balance Between Validity and Relevance

Questions About Internal Validity and Real-World Applicability in RCTs

Design for a Credible Effect That Matters Beyond the Trial

How to Cite This Guide

This guide is intended to be read, shared, and used in research, teaching, and academic work. If you draw on its ideas, explanations, or other content, please acknowledge the source by citing the guide. Doing so gives appropriate credit and helps your readers locate the original resource.